Cargando…
Active surveillance and focal therapy for low-intermediate risk prostate cancer
Low risk and many cases of low-intermediate risk prostate cancer, are indolent, have little or no metastatic potential, and are not life threatening. Major advances have been made in understanding who these patients are, and in encouraging the use of conservative management in such individuals. Cons...
Autor principal: | Klotz, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708232/ https://www.ncbi.nlm.nih.gov/pubmed/26816834 http://dx.doi.org/10.3978/j.issn.2223-4683.2015.06.03 |
Ejemplares similares
-
Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016) -
Active surveillance for low-risk prostate cancer
por: Klotz, Laurence
Publicado: (2012) -
Contemporary approach to active surveillance for favorable risk prostate cancer
por: Klotz, Laurence
Publicado: (2019) -
Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
por: Lawrentschuk, Nathan, et al.
Publicado: (2010) -
Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)